India link in fresh US insider trading scam
- Combating terrorism must be major priority for G20: PM Narendra Modi
- Obama on Paris attack: Twisted ideology behind killing of innocents
- G20 summit: India pledges to hike renewable energy output to 175GW by 2022
- Two attackers killed in Paris were Frenchmen living in Brussels
- Petrol price hiked by 36 paise/litre, diesel by 87 paise/litre
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
- Modi in Britain: Beyond a reiteration of good intentions, little was achieved
- The government’s version of the uniform civil code must be debated publicly
- Paris attacks: The loss of innocence
- How the AMU professor became a rallying point for LGBT movement
- Across the aisle: The ethos of India wins the election
- Salvation of India rests with Modi, provided he reforms himself